Exane Derivatives’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $989K | Buy |
7,435
+636
| +9% | +$84.6K | 0.57% | 42 |
|
|
2022
Q1 | $930K | Buy |
6,799
+1,019
| +18% | +$139K | 0.26% | 102 |
|
|
2021
Q4 | $1,000K | Sell |
5,780
-214
| -4% | -$37K | 0.24% | 92 |
|
|
2021
Q3 | $871K | Buy |
5,994
+440
| +8% | +$63.9K | 0.21% | 98 |
|
|
2021
Q2 | $750K | Sell |
5,554
-356
| -6% | -$48.1K | 0.17% | 113 |
|
|
2021
Q1 | $758K | Sell |
5,910
-1,713
| -22% | -$220K | 0.22% | 99 |
|
|
2020
Q4 | $908K | Buy |
+7,623
| New | +$908K | 0.27% | 92 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$108 | – | 652 |
|
|
2018
Q3 | $108 | Hold |
1
| – | – | ﹤0.01% | 575 |
|
|
2018
Q2 | $111 | Hold |
1
| – | – | ﹤0.01% | 572 |
|
|
2018
Q1 | $99 | Hold |
1
| – | – | ﹤0.01% | 523 |
|
|
2017
Q4 | $98 | Sell |
1
-1
| -50% | -$98 | ﹤0.01% | 495 |
|
|
2017
Q3 | $187 | Sell |
2
-14
| -88% | -$1.31K | ﹤0.01% | 447 |
|
|
2017
Q2 | $1.78K | Buy |
+16
| New | +$1.78K | ﹤0.01% | 411 |
|